Brief: Xspray Pharma Re-Submits FDA Application

Xspray Pharma publ AB

08/04/2025 06:41

April 8 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST:

RE-SUBMITS ITS FDA APPLICATION

FDA EXPECTED TO ANNOUNCE NEW PDUFA DATE FOR DASYNOC IN 2-4 WEEKS

Source text: ID:nMFN90WMHH

Further company coverage: XSPRAY.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))